Jakarta, IDN Times – PT Medela Potentia Tbk (MDLA) has announced a cash dividend distribution of Rp176.56 billion, equivalent to Rp12.6 per share, following its Annual General Meeting of Shareholders (AGMS) held in Jakarta on Tuesday (12/5/2026). Beyond the dividend payout, the meeting also ratified changes to the board of directors and outlined the company’s strategic growth roadmap for 2026, underscoring a period of solid performance and a commitment to delivering sustainable value to shareholders.
Dividend payout surges by 28.5 percent as company lifts ratio to 45 percent
Corporate Secretary Wimala Widjaja stated that this distribution reinforces the company’s ongoing dedication to providing consistent value since its initial public offering. While the company previously distributed 40 percent of its net profit as dividends, the board decided to increase the payout ratio to 45 percent for the 2025 financial year.
“The company has maintained its regular dividend of 40 percent of net profit while adding a supplemental 5 percent. The total dividend distributed amounts to Rp12.6 per share, a 28.5 percent increase compared to the previous year,” Wimala noted on Wednesday (13/5/2026).
MDLA posts strong performance with Rp4.03 trillion revenue
Financially, MDLA demonstrated robust momentum, recording a revenue of Rp4.03 trillion in the first quarter of 2026, marking a 3.4 percent year-on-year growth. The current period profit also climbed by 7.4 percent to Rp119.32 billion. This success was driven primarily by rising pharmaceutical sales and improved operational efficiency across the company’s distribution network.
Pharmaceutical products contributed Rp3.26 trillion to the revenue, up from Rp2.7 trillion in Q1 2025. Additionally, medical device sales reached Rp394.5 billion, while general health products accounted for Rp380.2 billion.
Investor Relations Director Harris Lesmana highlighted that the company is aggressively pursuing growth by strengthening distribution infrastructure, onboarding new principals, and fostering strategic collaborations in the medical device sector. In Q1 2026 alone, the company secured three new principals and is currently exploring partnerships with global entities to further expand its reach. Regarding ESG initiatives, MDLA continues to transition toward green logistics, operating a fleet of 106 electric motorcycles across 15 branches in 13 cities, alongside implementing free health checkup programs and fortifying Good Corporate Governance (GCG) practices.
New composition of Board of Directors and Commissioners
During the AGMS, shareholders formally approved the resignation of Krestijanto Pandji as President Director. The company expressed its gratitude for his significant contributions to corporate governance, business transformation, and the overall improvement of the company’s performance and adaptability.
Following the meeting, the new leadership structure for the Board of Directors and Board of Commissioners is as follows:
Board of Directors:
- President Director: Juliwaty
- Director: Wimala Widjaja
- Director: Edbert Orotodan
Board of Commissioners:
- President Commissioner: Stanley Ch. Budihardja
- Independent Commissioner: Lukas Setia Atmaja
Summary
PT Medela Potentia Tbk (MDLA) announced a cash dividend of Rp176.56 billion, or Rp12.6 per share, at its Annual General Meeting of Shareholders. This dividend distribution represents an increase in the payout ratio from 40% to 45% of net profit for the 2025 financial year, resulting in a 28.5% surge compared to the previous year.
The company reported strong financial performance, with Q1 2026 revenue reaching Rp4.03 trillion, a 3.4% year-on-year increase, and profit rising by 7.4% to Rp119.32 billion. Growth was driven by pharmaceutical sales and improved operational efficiency. MDLA also approved changes to its Board of Directors, appointing Juliwaty as President Director, and outlined strategies for future growth including strengthening distribution and exploring new partnerships.